Listing 1 - 4 of 4 |
Sort by
|
Choose an application
"Opioids. Concussions. Obesity. Climate change. America is a country of everyday crises -- big, long-spanning problems that persist, mostly unregulated, despite their toll on the country's health and vitality. And for every case of government inaction on one of these issues, there is a set of familiar, doubtful refrains: The science is unclear. The data is inconclusive. Regulation is unjustified. It's a slippery slope. Is it? The Triumph of Doubt traces the ascendance of science-for-hire in American life and government, from its origins in the tobacco industry in the 1950s to its current manifestations across government, public policy, and even professional sports. Well-heeled American corporations have long had a financial stake in undermining scientific consensus and manufacturing uncertainty; in The Triumph of Doubt, former Obama and Clinton official David Michaels details how bad science becomes public policy -- and where it's happening today. Amid fraught conversations of "alternative facts" and "truth decay," The Triumph of Doubt wields its unprecedented access to shine a light on the machinations and scope of manipulated science in American society. It is an urgent, revelatory work, one that promises to reorient conversations around science and the public good for the foreseeable future"--Provided by publisher.
Philosophy of science --- Social psychology --- Sociology of knowledge --- United States --- Public Health --- Research Support as Topic --- Industry --- Public-Private Sector Partnerships --- Deception --- Public Policy --- ethics --- Industry - ethics --- Public-Private Sector Partnerships - ethics --- United States of America --- Public health --- Industries
Choose an application
Vingt ans après leur introduction en France, les médicaments génériques suscitent toujours la polémique. Pour les uns, ce sont d'authentiques médicaments, dont dépend la survie de notre système d'assurance maladie. Pour les autres, ce sont de piètres copies qui sacrifient la santé à l'économie. Le développement des génériques a reconfiguré le système de santé français, en bouleversant les relations d'alliance et de concurrence entre les pouvoirs publics, les industriels, les professionnels de santé et les patients. Il a également révélé les conflits de valeurs qui traversent notre société : égalité contre qualité, solidarité contre liberté.
Médicaments génériques --- Politique pharmaceutique --- Économie de la santé --- Politique publique --- Industrie et commerce --- Sociologie de la santé --- Generic drugs --- Drugs, Generic --- Drug Industry --- Government Regulation --- Legislation, Drug --- Drugs --- ethics --- Therapeutic equivalency --- Sociologie de la santé. --- Generic drugs - France --- Drugs, Generic - France --- Drug Industry - ethics - France --- Government Regulation - France --- Legislation, Drug - France --- Drugs - Therapeutic equivalency - France
Choose an application
Drug Industry --- Drugs, Essential. --- Drugs. --- Health services accessibility. --- Intellectual Property. --- Intellectual property. --- Medical policy. --- Patent laws and legislation. --- Patents --- Pharmaceutical industry. --- World health. --- Ethics. --- Intellecutal Property --- Global Health --- Patents as Topic --- ethics. --- ethics --- Drug Industry - ethics. --- Patents as Topic - ethics --- Droit médical
Choose an application
The successes and failures of an industry that claims to protect and promote our online identitiesWhat does privacy mean in the digital era? As technology increasingly blurs the boundary between public and private, questions about who controls our data become harder and harder to answer. Our every web view, click, and online purchase can be sold to anyone to store and use as they wish. At the same time, our online reputation has become an important part of our identity—a form of cultural currency.The Identity Trade examines the relationship between online visibility and privacy, and the politics of identity and self-presentation in the digital age. In doing so, Nora Draper looks at the revealing two-decade history of efforts by the consumer privacy industry to give individuals control over their digital image through the sale of privacy protection and reputation management as a service.Through in-depth interviews with industry experts, as well as analysis of media coverage, promotional materials, and government policies, Draper examines how companies have turned the protection and promotion of digital information into a business. Along the way, she also provides insight into how these companies have responded to and shaped the ways we think about image and reputation in the digital age.Tracking the successes and failures of companies claiming to control our digital ephemera, Draper takes us inside an industry that has commodified strategies of information control. This book is a discerning overview of the debate around who controls our data, who buys and sells it, and the consequences of treating privacy as a consumer good.
Information technology --- Consumer protection --- Data protection --- Privacy --- Internet industry --- Social aspects --- Anonymizer. --- Commodification. --- Cypherpunks. --- Digital culture. --- Environmental movement. --- Government regulation. --- Image promotion. --- Individualization. --- Industry ethics. --- Industry self-regulation. --- Infomediaries. --- Internet. --- Managed visibility. --- Neoliberalism. --- Online reputation management. --- Personal data ecosystem. --- Personal data. --- Personal information. --- Political economy. --- Public pedagogy. --- Search engine optimization. --- Self-branding. --- Self-knowledge. --- Self-presentation. --- Self-tracking. --- Strategic transparency. --- Surveillance. --- Technology. --- Visibility. --- media. --- self-discovery. --- technology industries.
Listing 1 - 4 of 4 |
Sort by
|